Ventyx Biosciences Earnings Estimate

VTYX Stock  USD 3.03  0.08  2.71%   
The next projected EPS of Ventyx Biosciences is estimated to be -0.471775 with future projections ranging from a low of -0.5225 to a high of -0.3975. Ventyx Biosciences' most recent 12-month trailing earnings per share (EPS TTM) is at -1.74. Please be aware that the consensus of earnings estimates for Ventyx Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Ventyx Biosciences is projected to generate -0.471775 in earnings per share on the 31st of December 2025. Ventyx Biosciences earnings estimates show analyst consensus about projected Ventyx Biosciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Ventyx Biosciences' historical volatility. Many public companies, such as Ventyx Biosciences, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Ventyx Biosciences' earnings estimates, investors can diagnose different trends across Ventyx Biosciences' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to rise to about (804.6 K) in 2025Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ventyx Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Ventyx Biosciences Earnings Estimation Breakdown

The calculation of Ventyx Biosciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Ventyx Biosciences is estimated to be -0.471775 with the future projection ranging from a low of -0.5225 to a high of -0.3975. Please be aware that this consensus of annual earnings estimates for Ventyx Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
-0.52
Lowest
Expected EPS
-0.471775
-0.4
Highest

Ventyx Biosciences Earnings Projection Consensus

Suppose the current estimates of Ventyx Biosciences' value are higher than the current market price of the Ventyx Biosciences stock. In this case, investors may conclude that Ventyx Biosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Ventyx Biosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
975.06%
0.0
-0.471775
-1.74

Ventyx Biosciences Earnings per Share Projection vs Actual

Actual Earning per Share of Ventyx Biosciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Ventyx Biosciences predict the company's earnings will be in the future. The higher the earnings per share of Ventyx Biosciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Ventyx Biosciences Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Ventyx Biosciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Ventyx Biosciences should always be considered in relation to other companies to make a more educated investment decision.

Ventyx Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Ventyx Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
null
nullnullnullnull
2025-06-05
2025-03-31-0.69-0.390.343 
2025-02-27
2024-12-31-0.5413-0.410.131324 
2024-11-04
2024-09-30-0.52-0.50.02
2024-08-09
2024-06-30-0.58-0.450.1322 
2024-05-09
2024-03-31-0.69-0.620.0710 
2024-02-27
2023-12-31-0.9-0.790.1112 
2023-11-09
2023-09-30-0.9-0.92-0.02
2023-08-10
2023-06-30-0.71-0.91-0.228 
2023-05-11
2023-03-31-0.65-0.68-0.03
2023-03-23
2022-12-31-0.64-0.620.02
2022-11-03
2022-09-30-0.44-0.59-0.1534 
2022-08-15
2022-06-30-0.45-0.390.0613 
2022-05-12
2022-03-31-0.52-0.450.0713 
2022-03-23
2021-12-31-1-0.360.6464 
2021-11-17
2021-09-30-0.36-3.17-2.81780 
2021-06-30
2021-03-310-0.9247-0.9247
2021-03-31
2020-12-310-0.9247-0.9247
2020-06-30
2020-03-310-0.1153-0.1153
2020-03-31
2019-12-310-0.1153-0.1153

About Ventyx Biosciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Ventyx Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Ventyx Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Ventyx Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-554.3 M-526.6 M
Retained Earnings Total Equity-203.6 M-213.8 M
Earnings Yield(0.90)(0.86)
Price Earnings Ratio(1.11)(1.17)
Price Earnings To Growth Ratio 0.03  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.